Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine
· Delayed Price · Currency is JOD · Price in USD 3.700
-0.100 (-2.63%)
At close: Feb 26, 2025
PEX:BPC Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 25, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 102 | 120 | 121 | 78 | 73 | 72 | Upgrade
|
| Market Cap Growth | -9.45% | -0.93% | 56.41% | 6.71% | 1.34% | 3.59% | Upgrade
|
| Enterprise Value | 93 | 109 | 111 | 72 | 70 | 65 | Upgrade
|
| Last Close Price | 2.63 | 3.07 | 3.02 | 1.90 | 1.73 | 1.64 | Upgrade
|
| PE Ratio | 39.53 | 27.70 | 21.51 | 9.07 | 13.92 | 10.63 | Upgrade
|
| PS Ratio | 3.72 | 3.93 | 3.63 | 2.41 | 2.86 | 2.93 | Upgrade
|
| PB Ratio | 1.43 | 1.61 | 1.65 | 1.18 | 1.29 | 1.29 | Upgrade
|
| P/TBV Ratio | 1.51 | 1.62 | 1.67 | 1.19 | 1.30 | 1.30 | Upgrade
|
| P/FCF Ratio | 36.47 | 19.18 | 105.72 | 40.29 | 20.01 | 14.80 | Upgrade
|
| P/OCF Ratio | 28.72 | 13.93 | 32.84 | 30.02 | 18.22 | 9.16 | Upgrade
|
| EV/Sales Ratio | 3.45 | 3.55 | 3.34 | 2.23 | 2.76 | 2.64 | Upgrade
|
| EV/EBITDA Ratio | 17.42 | 17.63 | 13.99 | 8.45 | 11.54 | 9.69 | Upgrade
|
| EV/EBIT Ratio | 21.47 | 21.30 | 16.42 | 9.82 | 14.37 | 11.68 | Upgrade
|
| EV/FCF Ratio | 33.36 | 17.32 | 97.07 | 37.24 | 19.28 | 13.36 | Upgrade
|
| Debt / Equity Ratio | - | - | 0.01 | 0.02 | 0.04 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.11 | 0.17 | 0.37 | 0.46 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.75 | 0.75 | 0.62 | 0.64 | Upgrade
|
| Asset Turnover | 0.31 | 0.35 | 0.40 | 0.43 | 0.36 | 0.37 | Upgrade
|
| Inventory Turnover | 1.95 | 2.22 | 2.53 | 2.36 | 1.83 | 1.64 | Upgrade
|
| Quick Ratio | 5.54 | 6.58 | 7.15 | 6.51 | 5.01 | 5.68 | Upgrade
|
| Current Ratio | 7.02 | 8.22 | 9.01 | 8.31 | 6.84 | 7.52 | Upgrade
|
| Return on Equity (ROE) | 3.47% | 5.90% | 8.08% | 14.10% | 9.31% | 12.64% | Upgrade
|
| Return on Assets (ROA) | 3.10% | 3.62% | 5.09% | 6.11% | 4.36% | 5.20% | Upgrade
|
| Return on Capital (ROIC) | 3.69% | 4.28% | 5.99% | 7.25% | 5.18% | 6.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.45% | 6.14% | 8.28% | 9.84% | 7.50% | 8.57% | Upgrade
|
| Earnings Yield | 2.48% | 3.61% | 4.65% | 11.03% | 7.18% | 9.40% | Upgrade
|
| FCF Yield | 2.74% | 5.21% | 0.95% | 2.48% | 5.00% | 6.75% | Upgrade
|
| Dividend Yield | 1.35% | 1.16% | 2.35% | 1.86% | 3.01% | 4.66% | Upgrade
|
| Payout Ratio | 54.18% | 63.39% | 24.39% | 23.60% | 56.73% | 29.93% | Upgrade
|
| Buyback Yield / Dilution | -1.00% | -1.00% | 2.38% | - | - | - | Upgrade
|
| Total Shareholder Return | 0.35% | 0.16% | 4.73% | 1.86% | 3.01% | 4.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.